好想你: 2025年半年度财务报告

Core Viewpoint - The financial report of Haoxiangni Health Food Co., Ltd. for the first half of 2025 indicates a significant decline in both revenue and net profit compared to the same period in 2024, reflecting challenges in the company's operational performance and financial health [1][2][3]. Financial Performance - Total operating revenue for the first half of 2025 was CNY 688,730,956.56, down from CNY 816,408,064.23 in the same period of 2024, representing a decrease of approximately 15.7% [3][4]. - Total operating costs decreased to CNY 697,332,651.41 from CNY 871,932,093.54, a reduction of about 20% [3][4]. - The net profit for the first half of 2025 was a loss of CNY 19,849,927.37, compared to a loss of CNY 37,135,745.40 in the first half of 2024, indicating an improvement in net loss [4][5]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,428,129,712.65, down from CNY 4,890,765,768.80 at the beginning of the period [1][2]. - Total liabilities decreased to CNY 1,352,470,728.09 from CNY 1,363,374,295.09, showing a slight reduction in financial obligations [2][3]. - The total equity attributable to shareholders decreased to CNY 3,107,653,649.33 from CNY 3,559,523,361.15, reflecting a decline in shareholder value [2][3]. Cash Flow Analysis - Net cash flow from operating activities was CNY 113,907,688.14, an increase from CNY 30,552,830.78 in the previous year, indicating improved cash generation from core operations [5][6]. - Cash flow from investing activities generated a net inflow of CNY 252,143,983.92, down from CNY 285,603,081.14, suggesting a decrease in investment returns [5][6]. - Cash flow from financing activities resulted in a net outflow of CNY 386,743,204.02, compared to a net outflow of CNY 423,754,585.17 in the previous year, indicating a reduction in financing costs [5][6].